{"id":"https://genegraph.clinicalgenome.org/r/9396fb77-dd99-4da7-bcd0-a5a6db75379av1.0","type":"EvidenceStrengthAssertion","dc:description":"The *SLC34A1* gene is located on chromosome 5 at q35.3 and encodes the Solute Carrier Family 34 Member 1. \n\nMultiple disease entities have been reported in association with this gene. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, there was evidence of differences in their molecular mechanism, inheritance pattern and phenotypic spectrum. Therefore, the following disease entities have been lumped into one disease entity: Hypercalcemia, infantile, 2 (OMIM: 616963) and Nephrolithiasis/osteoporosis, hypophosphatemic, 1 (OMIM:612286), and split from Fanconi renotubular syndrome 2 (OMIM:613388). The preferred disease name suggested for this lumped autosomal recessive disorder is ‘Infantile hypercalcemia - *SLC34A1*’. Heterozygous carriers of pathogenic variants are at an increased risk of developing nephrolithiasis, as associated with autosomal dominant hypophosphatemic nephrolithiasis/osteoporosis 1. Autosomal recessive Fanconi renotubular syndrome 2 has been curated separately. \n\n*SLC34A1* was first reported in relation to autosomal recessive infantile hypercalcemia in 2014 (Rajagopal et al., PMID: 25050900). The mechanism of pathogenicity is known to be loss of function. Infantile hypercalcemia is characterized by severe hypercalcemia, with failure to thrive, vomiting, dehydration, and nephrocalcinosis.\n\nAt least 15 variants (missense, deletions, nonsense, frameshift, and splice site) have been reported in 10 probands in 3 publications (PMIDs: 25050900, 26047794, 30943683 included in this curation). Of note, the c.272_292del (p.Val91_Ala97del) variant included in this curation is a noted polymorphism that can be causative of disease when inherited in trans with another pathogenic variant. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached, considering case-level data. \n\nThis gene-disease association is also supported by mouse models phenocopying disease in human patients, expression studies at the brush border of proximal tubule cells in humans, biochemical function critical to actively transporting phosphate into cells via Na+ cotransport, and functional alteration demonstrating multiple variants are unable to produce Pi uptakes comparable to the wild type (PMIDs: 8327470, 9560283, 20335586, 26047794). More evidence is available in the literature, but the maximum score for experimental evidence (6 pts.) has been reached.\n\nIn summary, there is definitive evidence supporting the relationship between SLC34A1 and autosomal recessive infantile hypercalcemia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/9396fb77-dd99-4da7-bcd0-a5a6db75379a","GCISnapshot":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10067","date":"2022-10-19T13:30:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10067","date":"2024-01-09T06:13:28.185Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/241553f7-593c-4d90-9d12-1b371e2f7168_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4b57bf4-644d-4a43-994b-cc3d1f069aa7","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f4b57bf4-644d-4a43-994b-cc3d1f069aa7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30943683","allele":{"id":"https://genegraph.clinicalgenome.org/r/08167715-37c1-4e42-a4bd-eb1c41f751ef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1337G>A (p.Gly446Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580758"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/2fa6116f-ced5-4247-a2cf-c851d2e9da20","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2fa6116f-ced5-4247-a2cf-c851d2e9da20_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30943683","allele":{"id":"https://genegraph.clinicalgenome.org/r/42e7731b-b7b1-4874-bf36-bcc92ead99e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1483C>T (p.Arg495Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580812"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/241553f7-593c-4d90-9d12-1b371e2f7168","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/30943683","rdfs:label":"Kang Proband","ageType":"AgeAtReport","ageUnit":"Days","ageValue":28,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/08167715-37c1-4e42-a4bd-eb1c41f751ef"},{"id":"https://genegraph.clinicalgenome.org/r/42e7731b-b7b1-4874-bf36-bcc92ead99e8"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"2 ASDs, stool frequency: once/week, urine output: 7.7 mL/kg/day, Ht: 25th %ile, Wt: 15-25th %ile","phenotypes":["obo:HP_0012408","obo:HP_0004719"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f4b57bf4-644d-4a43-994b-cc3d1f069aa7_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/2fa6116f-ced5-4247-a2cf-c851d2e9da20_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/912a7dd0-7bec-4523-90e9-d0929aa9936c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ad03ef2-571c-485f-b3f1-6e202a8db6d2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6ad03ef2-571c-485f-b3f1-6e202a8db6d2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.G153A showed completely intracellular retention and no detectable actin colocalization, WT localized at plasma membrane colocalizing with actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6ad03ef2-571c-485f-b3f1-6e202a8db6d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/f2db016c-ef30-4912-91a6-34c61f037127","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.458G>C (p.Gly153Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10581121"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/53792470-eb1a-4afd-a7c5-6aec6612046d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53792470-eb1a-4afd-a7c5-6aec6612046d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.C336G showed completely intracellular retention and no detectable actin colocalization, WT localized at plasma membrane colocalizing with actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/53792470-eb1a-4afd-a7c5-6aec6612046d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/ffaf1017-2afc-4ec9-b34a-ae80c1845718","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1006T>G (p.Cys336Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10581120"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/912a7dd0-7bec-4523-90e9-d0929aa9936c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F4.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/ffaf1017-2afc-4ec9-b34a-ae80c1845718"},{"id":"https://genegraph.clinicalgenome.org/r/f2db016c-ef30-4912-91a6-34c61f037127"}],"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate, Reduced TmP/GFR, Reduced PTH","phenotypes":["obo:HP_0003072","obo:HP_0002150","obo:HP_0001824","obo:HP_0000121","obo:HP_0001508"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/6ad03ef2-571c-485f-b3f1-6e202a8db6d2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/53792470-eb1a-4afd-a7c5-6aec6612046d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/84e283b4-f812-47a3-be39-3f25352b9455_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a4b9506-78e0-47c6-bb93-3acbe402bb08","type":"EvidenceLine","dc:description":"The variant was reduced by 0.5 points for homozygosity and consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4a4b9506-78e0-47c6-bb93-3acbe402bb08_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/9b42e340-8a02-42bf-9f92-9912a6315d60","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.644+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580462"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/84e283b4-f812-47a3-be39-3f25352b9455","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F1.1","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":20,"allele":{"id":"https://genegraph.clinicalgenome.org/r/9b42e340-8a02-42bf-9f92-9912a6315d60"},"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate, Reduced TmP/GFR, Reduced intact parathyroid hormone levels, Elevated Calcitriol","phenotypes":["obo:HP_0001252","obo:HP_0000103","obo:HP_0002150","obo:HP_0001508","obo:HP_0000121","obo:HP_0003072","obo:HP_0001824","obo:HP_0001944"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/4a4b9506-78e0-47c6-bb93-3acbe402bb08_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/40f7e03d-d758-49a3-983b-168d389784b2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b0e59bc-c456-41cc-9c4e-10f5c2e03849","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8b0e59bc-c456-41cc-9c4e-10f5c2e03849_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.G153V showed completely intracellular retention and no detectable actin colocalization, WT localized at plasma membrane colocalizing with actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8b0e59bc-c456-41cc-9c4e-10f5c2e03849_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/230fa3fd-36e1-4fb4-804d-73f8aec1ab5e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.458G>T (p.Gly153Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580394"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6f6f1ce0-34aa-4282-bff9-afe32aa38c42","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6f6f1ce0-34aa-4282-bff9-afe32aa38c42_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.W488R showed completely intracellular retention and no detectable actin colocalization, WT localized at plasma membrane colocalizing with actin","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/6f6f1ce0-34aa-4282-bff9-afe32aa38c42_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/987079b3-fcc4-4363-b924-3f11d70ef727","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1462T>C (p.Trp488Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362316159"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/40f7e03d-d758-49a3-983b-168d389784b2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F10.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/987079b3-fcc4-4363-b924-3f11d70ef727"},{"id":"https://genegraph.clinicalgenome.org/r/230fa3fd-36e1-4fb4-804d-73f8aec1ab5e"}],"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate, Reduced TmP/GFR, Reduced PTH","phenotypes":["obo:HP_0001824","obo:HP_0000121","obo:HP_0002150","obo:HP_0001944","obo:HP_0001508","obo:HP_0003072","obo:HP_0000103"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/8b0e59bc-c456-41cc-9c4e-10f5c2e03849_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/6f6f1ce0-34aa-4282-bff9-afe32aa38c42_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/31cc52e9-ccd3-4507-98c2-4868076f71f9_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fd39edd-4cba-48a6-a763-579ca2f01be4","type":"EvidenceLine","dc:description":"The score was reduced due to homozygosity to avoid over-scoring this occurrence.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3fd39edd-4cba-48a6-a763-579ca2f01be4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Phosphate uptake assays in HEK 293 cells showed the inability of this variant to transport phosphate","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/3fd39edd-4cba-48a6-a763-579ca2f01be4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25050900","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a42f7ed-e3af-4080-a78e-919c95e32e38","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1484G>A (p.Arg495His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580813"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/31cc52e9-ccd3-4507-98c2-4868076f71f9","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25050900","rdfs:label":"Argentinian Sibling","ageType":"AgeAtReport","ageUnit":"Years","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a42f7ed-e3af-4080-a78e-919c95e32e38"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Vitamin D prophylaxis (500 IU/d) with 25(OH)2D3 serum levels in the upper normal range and elevated 1,25(OH)2D3 levels.","phenotypes":["obo:HP_0003072","obo:HP_0002148","obo:HP_0002150","obo:HP_0000121","obo:HP_0004322","obo:HP_0000829"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3fd39edd-4cba-48a6-a763-579ca2f01be4_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e1c7fec9-83d1-4697-8b4f-1cdaecf76add_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c35c9f9-9535-4f70-83a0-5f3019660d69","type":"EvidenceLine","dc:description":"The variant was reduced due to homozygosity to avoid over-scoring this occurrence.","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2c35c9f9-9535-4f70-83a0-5f3019660d69_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"p.G153V showed completely intracellular retention and no detectable actin colocalization, WT localized at plasma membrane colocalizing with actin.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2c35c9f9-9535-4f70-83a0-5f3019660d69_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/230fa3fd-36e1-4fb4-804d-73f8aec1ab5e"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e1c7fec9-83d1-4697-8b4f-1cdaecf76add","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F2.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/230fa3fd-36e1-4fb4-804d-73f8aec1ab5e"},"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate, Reduced TmP/GFR, Elevated Calcitriol","phenotypes":["obo:HP_0002150","obo:HP_0000121","obo:HP_0003072"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/2c35c9f9-9535-4f70-83a0-5f3019660d69_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a0f5aa38-fb6e-4014-9ecd-b993472e0128_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43bb8d77-16c5-4052-b11c-620bea19ad10","type":"EvidenceLine","dc:description":"This occurrence was downgraded by 0.5 points for homozygosity and consanguinity.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/43bb8d77-16c5-4052-b11c-620bea19ad10_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/5a422ee4-b242-41f4-8dc0-ede9d3133171","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1006+1G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580594"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a0f5aa38-fb6e-4014-9ecd-b993472e0128","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F3.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/5a422ee4-b242-41f4-8dc0-ede9d3133171"},"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate","phenotypes":["obo:HP_0000121","obo:HP_0001824","obo:HP_0001944","obo:HP_0003072","obo:HP_0002150","obo:HP_0001508","obo:HP_0000103"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/43bb8d77-16c5-4052-b11c-620bea19ad10_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ef099778-80d5-4c9c-b471-39d2c161f880_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f315aa5-5418-4fc9-8101-9500f1b89251","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f315aa5-5418-4fc9-8101-9500f1b89251_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"This variant has been noted as a polymorphism and is benign in ClinVar, but has been shown to cause disease when inherited with another pathogenic variant in trans.","functionalDataSupport":"No"},{"id":"https://genegraph.clinicalgenome.org/r/7f315aa5-5418-4fc9-8101-9500f1b89251_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/68243a92-42c1-4a8b-b553-fd02b5304250","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.272_292del (p.Val91_Ala97del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580329"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/604a96f2-c479-4332-8fac-0cb470664a93","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/604a96f2-c479-4332-8fac-0cb470664a93_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/3dbf3709-e63a-4b7f-b813-c4aaf42a5667","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.914G>A (p.Trp305Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362366206"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ef099778-80d5-4c9c-b471-39d2c161f880","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F8.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/3dbf3709-e63a-4b7f-b813-c4aaf42a5667"},{"id":"https://genegraph.clinicalgenome.org/r/68243a92-42c1-4a8b-b553-fd02b5304250"}],"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate, Elevated TmP/GFR","phenotypes":["obo:HP_0003072","obo:HP_0002150","obo:HP_0000121","obo:HP_0000103","obo:HP_0001944","obo:HP_0001508","obo:HP_0001824"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/604a96f2-c479-4332-8fac-0cb470664a93_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7f315aa5-5418-4fc9-8101-9500f1b89251_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/a733862a-5b75-4969-b880-42afa682c54e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b4e6ee2-8c40-4f4e-958d-10870f398348","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3b4e6ee2-8c40-4f4e-958d-10870f398348_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/bfab138a-741a-48f9-a370-dcf56c5842ec","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1614G>A (p.Trp538Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580846"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3104a288-7fb4-4975-857a-7ad08995c3fe","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3104a288-7fb4-4975-857a-7ad08995c3fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/54a39ce7-8d5c-4857-acac-6a04b0d16933","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1006+3_1006+6del","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573320646"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/a733862a-5b75-4969-b880-42afa682c54e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F11.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":4,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/54a39ce7-8d5c-4857-acac-6a04b0d16933"},{"id":"https://genegraph.clinicalgenome.org/r/bfab138a-741a-48f9-a370-dcf56c5842ec"}],"firstTestingMethod":"Genotyping","phenotypeFreeText":"Reduced serum phosphate, Reduced PTH, Elevated vitamin D","phenotypes":["obo:HP_0000121","obo:HP_0001944","obo:HP_0001508","obo:HP_0001824","obo:HP_0000103","obo:HP_0003072"],"secondTestingMethod":"Sanger sequencing","sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/3104a288-7fb4-4975-857a-7ad08995c3fe_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3b4e6ee2-8c40-4f4e-958d-10870f398348_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/c23dd17c-dbe8-4bee-9ece-7a5f909ad714_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f039be83-72ef-4065-be95-e29a7abc7788","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f039be83-72ef-4065-be95-e29a7abc7788_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c0dce3e-60b4-41e3-be0c-37fc10ca1a1b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.557_558del (p.Pro186HisfsTer26)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA447742004"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/b62d437a-e9e7-47f8-bf4d-f7ccc1ef8ed6","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b62d437a-e9e7-47f8-bf4d-f7ccc1ef8ed6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","allele":{"id":"https://genegraph.clinicalgenome.org/r/31d84243-9e63-45fd-9466-5f72d370b8bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003052.5(SLC34A1):c.1416+5G>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3580778"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/c23dd17c-dbe8-4bee-9ece-7a5f909ad714","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"F14.1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/31d84243-9e63-45fd-9466-5f72d370b8bb"},{"id":"https://genegraph.clinicalgenome.org/r/9c0dce3e-60b4-41e3-be0c-37fc10ca1a1b"}],"phenotypeFreeText":"Elevated phosphate serum, Reduced PTH","phenotypes":["obo:HP_0001944","obo:HP_0001508","obo:HP_0001824","obo:HP_0000121","obo:HP_0002150","obo:HP_0000103","obo:HP_0003072"],"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/f039be83-72ef-4065-be95-e29a7abc7788_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/b62d437a-e9e7-47f8-bf4d-f7ccc1ef8ed6_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c307565-ad7e-4f89-b186-c884175906ad","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1acf2bb-a763-4c4e-a956-773e82f557c6","type":"Finding","dc:description":"This mouse model phenocopies patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9560283","rdfs:label":"Beck Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/8187854c-b8b9-4e33-948a-cff59921b35c","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f05d5406-b6d0-4584-9ff6-699df1e1f5b8","type":"Finding","dc:description":"SLC34A1 KO mice fed lowP diets led to severe hypophosphatemia in KO but not WT. HighD diets resulted in vitamin D overload in KO and WT reflected by high 25-OH-D3. WT mice were able to down-regulate vitamin D whereas KO could not, worsening hypercalcemia and hypercalciuria. These phenocopied patients closely.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"Schlingmann Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9c5f6e5a-d24f-43bc-8dc8-3fb63649a44f","type":"EvidenceLine","dc:description":"0.5 is scored for both variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42bb940f-a0cb-4e26-a915-758ab092ca18","type":"FunctionalAlteration","dc:description":"Overexpression of WT NaPi-IIa induced a significant Pi uptake while injection of variant (G153A and G153V) NaPi-IIa cRNA did not produce Pi uptakes significantly different from non-injected controls, compatible with a loss of function and/or defective trafficking to the membrane of identified mutations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"Variant NaPi-IIa cRNA did not produce Pi uptakes pt. 1"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/60287b74-cb49-4adc-9b2a-8ec95e5c6f26","type":"EvidenceLine","dc:description":"0.5 is scored for both variants.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/01af50af-88c0-4703-9cb9-18143530fa16","type":"FunctionalAlteration","dc:description":"Overexpression of WT NaPi-IIa induced a significant Pi uptake while injection of variant (C336G and W488R) NaPi-IIa cRNA did not produce Pi uptakes significantly different from non-injected controls, compatible with a loss of function and/or defective trafficking to the membrane of identified mutations.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26047794","rdfs:label":"Variant NaPi-IIa cRNA did not produce Pi uptakes pt. 2"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/1b164a17-9f7b-43b2-88b2-2adb8e458c08_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/810d0e75-cef0-4534-9c4f-6a00ac7b7f2c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/986ab957-cb0d-4a32-82f3-8f7135616cb8","type":"Finding","dc:description":"This biochemical functions highlights why dysfunction of the SLC34A1 protein may cause tubulopathy.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20335586","rdfs:label":"Active transport of phosphate into cells via Na+ cotransport","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/7ad947cb-cb86-4eef-9022-ef46e8a1602e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/73608d6f-80e8-4261-a9a9-c1ed1f6b9de5","type":"Finding","dc:description":"SLC34A1 is highly expressed at the brush border of proximal tubule cells in humans","dc:source":"https://pubmed.ncbi.nlm.nih.gov/8327470","rdfs:label":"Expression at brush border of proximal tubule cells","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6}],"evidenceStrength":"Definitive","sequence":7451,"specifiedBy":"GeneValidityCriteria9","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/zqW6fEx6jFM","type":"GeneValidityProposition","disease":"obo:MONDO_0014851","gene":"hgnc:11019","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_1b164a17-9f7b-43b2-88b2-2adb8e458c08-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}